FDA Inspection 996806 — Natren Inc.
The FDA completed an inspection of Natren Inc. on December 21, 2016 in Thousand Oaks, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 21, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Thousand Oaks, CA (United States)